TransMedics Group, Inc. Profile Avatar - Palmy Investing

TransMedics Group, Inc.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable…
Medical - Devices
US, Andover [HQ]

Balance Sheet

8 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2016 2017 2018 2019 2020 2021 2022 2023
Assets
- - 37.00 42.00 105.00 152.00 134.00 277.00 706.00
Current
- - 34.00 34.00 100.00 146.00 118.00 252.00 510.00
Non Current
- - 2.00 7.00 5.00 5.00 16.00 24.00 195.00
Liabilities
- - 205.00 46.00 50.00 48.00 67.00 89.00 568.00
Current
- - 10.00 12.00 16.00 11.00 23.00 23.00 54.00
Non Current
- - 194.00 34.00 34.00 36.00 43.00 66.00 513.00
Equity
- - -168.00 -4.00 54.00 103.00 67.00 187.00 137.00
Stockholders' Equity
- - -168.00 -4.00 54.00 103.00 67.00 187.00 137.00
Retained Earnings
- - -312.00 -335.00 -369.00 -398.00 -442.00 -478.00 -503.00
Common Stock
- - - - 331.00 424.00 502.00 510.00 666.00 641.00
Preferred Stock
- - - - - - - - - - - - - - - -
Profit
-24.00 -20.00 -23.00 -33.00 -28.00 -44.00 -36.00 -25.00
Dividends
- - - - - - - - - - - - - - - -
Minority Interest
- - - - - - - - - - - - - - - -
Other Stockholders' Equity
- - 143.00 - - - - - - - - - - - -
Loss Other Compr. Income
- - - - - - - - - - - - - - - -
End of TMDX's Analysis
CIK: 1756262 CUSIP: 89377M109 ISIN: US89377M1099 LEI: - UEI: -
Secondary Listings
TMDX has no secondary listings inside our databases.